Mixed ventilatory defects in pulmonary sarcoidosis: prevalence and prognosis
V. Kouranos (London, United Kingdom), S. Ward (London, United Kingdom), M. Kokosi (London, United Kingdom), S. Thomas (London, United Kingdom), D. Castillo (London, United Kingdom), E. Judge (London, United Kingdom), F. Van Tonder (London, United Kingdom), A. Devaraj (London, United Kingdom), T. Maher (London, United Kingdom), E. Renzoni (London, United Kingdom), A. Wells (London, United Kingdom)
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Session: Sarcoidosis: from basic research to patient outcomes
Session type: Poster Discussion
Number: 5210
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Kouranos (London, United Kingdom), S. Ward (London, United Kingdom), M. Kokosi (London, United Kingdom), S. Thomas (London, United Kingdom), D. Castillo (London, United Kingdom), E. Judge (London, United Kingdom), F. Van Tonder (London, United Kingdom), A. Devaraj (London, United Kingdom), T. Maher (London, United Kingdom), E. Renzoni (London, United Kingdom), A. Wells (London, United Kingdom). Mixed ventilatory defects in pulmonary sarcoidosis: prevalence and prognosis. 5210
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis Source: Eur Respir J, 58 (2) 2003345; 10.1183/13993003.03345-2020 Year: 2021
Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema Source: Eur Respir J 2011; 37: 176-183 Year: 2011
Clinical characteristics, haemodynamics, and survival in patients with combined pulmonary fibrosis and emphysema and associated pulmonary hypertension Source: Annual Congress 2008 - Pulmonary vascular medicine Year: 2008
Pulmonary hypertension in patients with idiopathic pulmonary fibrosis and combined pulmonary fibrosis and emphysema: hemodynamic severity Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018
Comparison of clinical characteristics and prognosis in patients with idiopathic pulmonary upper lobe predominant pulmonary fibrosis and idiopathic pulmonary fibrosis Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) Year: 2018
‘Idiopathic‘ pulmonary arterial hypertension with preserved lung function but co-existing parenchymal abnormalities: Response to treatment and survival Source: Annual Congress 2012 - Pulmonary circulation: clinical databases and registries Year: 2012
Prognostic value of right ventricular function in patients with severe pulmonary hypertension associated with respiratory disease Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013
Coexistent pulmonary emphysema delays the decrease in vital capacity in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008
Echocardiographic assessment of cardiac function in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015
Severe pulmonary hypertension in patients with emphysema but preserved FEV1: Prognosis and response to treatment Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013
Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 40: 93-100 Year: 2012
Prevalence and impact of WHO group 3 pulmonary hypertension in advanced idiopathic nonspecific interstitial pneumonia Source: Eur Respir J, 52 (1) 1800545; 10.1183/13993003.00545-2018 Year: 2018
Early diagnosis of invasive pulmonary aspergillus in patients with chronic obstructive pulmonary diseases: a case control study Source: International Congress 2019 – Airway infection in COPD Year: 2019
Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosis Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015
Prognosis of pulmonary sarcoidosis in young patients Source: Eur Respir J 2003; 22: Suppl. 45, 45s Year: 2003
Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013
Pulmonary arterial hypertension associated with sarcoidosis (BBS-PAH): mechanisms, hemodynamics and prognosis Source: Eur Respir J 2002; 20: Suppl. 38, 371s Year: 2002
A vasomotor form of the endothelial dysfunction of the microvasculature in patients with a chronic obstructive pulmonary disease, and in combination with the pulmonary embolism Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015
Sarcopenia in idiopathic pulmonary fibrosis (IPF): Prevalence and response to pulmonary rehabilitation (PR) Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation Year: 2020
Interstitial lung diseases in childhood Source: ISSN=1025-448x, ISBN=1-904097-22-7, page=213 Year: 2002